Books > Medicine > Clinical & internal medicine > Gynaecology & obstetrics
|
Not currently available
Ovarian Cancers - Advances through International Research Cooperation (GINECO, ENGOT, GCIG) (Hardcover, 1st ed. 2017)
Loot Price: R2,928
Discovery Miles 29 280
You Save: R176
(6%)
|
|
Ovarian Cancers - Advances through International Research Cooperation (GINECO, ENGOT, GCIG) (Hardcover, 1st ed. 2017)
Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.
|
This book provides an overview of the latest developments in the
concepts and management of ovarian cancer. The new data presented
throughout opens the way to radically different therapeutic
approaches. Surgery remains the core of ovarian cancer treatment,
but its ultimate goal and the standard surgical procedure have
evolved, giving rise to the question of how to label expert centers
for debulking surgery. Neo-adjuvant chemotherapy is becoming more
popular and is also a new field for testing novel drug
combinations. Over recent years, ovarian cancer management has
embraced molecular biology. It is now more correct to talk about
cancers of the ovary rather than ovarian cancer, since it is not a
unique disease but several entities with different molecular
drivers. The significant advances in drugs targeting the
microenvironment or the tumor cell DNA repair mechanisms are
presented in detail together with exciting future perspectives. All
these advances would not have been possible without collaborative
groups such as the GINECO group in France and their integration in
wider clinical research networks at the European (ENGOT) and
international (GCIG) level.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.